Christine Hohenadl

Christine Hohenadl has a diverse and impressive work experience across various companies and roles. Christine started their career at Ausrianova Biotechnology GmbH in 2000, where they worked as the Head of R&D New Therapeutic Genes and Delivery Vectors until 2007. Christine then joined the Paul-Ehrlich-Institut as an Assessor for Gene Therapy Medicinal Products from 2007 to 2008. From there, they worked as a Visiting Professor at the University of Veterinary Medicine Vienna from 2008 to 2010. Christine then joined Baxter Bioscience in 2010 as a Manager of R&D, where they stayed until 2014. Currently, they are working as the Head of Raw Material R&D at Croma Pharma since 2016.

Christine Hohenadl completed their education in a chronological manner. From 1983 to 1988, they attended Ludwig-Maximilians-Universität München, where they pursued a degree in Biologie and earned a Doctor rer nat. Following this, they went on to pursue further studies at the University of Veterinary Medicine from 2000 to 2004, specializing in Virology and obtaining a Habilitation degree.